Published Date: 04 Mar 2023
Germany: A recent study shows that female hormone therapy increases the risk of cerebral hemorrhage in patients with cerebral hemorrhage.
Read Full NewsPeople with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.
Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.
Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.
In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease.
The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.
Adalimumab and tocilizumab perform similarly in controlling inflammation while reducing the use of corticosteroids at week 16 in patients with refractory, noninfectious uveitis.
Metabolic syndrome, rather than BMI or waist circumference, is linked to an increased likelihood of glaucoma and may better identify adults who could benefit from closer eye screening.
1.
Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.
2.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
3.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
4.
Cancer mortality continuing to decline, says report
5.
Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain
1.
Unmasking the Subtle Symptoms of Colon Cancer
2.
Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies
3.
The Basics of M.C.V Normal Range for Better Health Management
4.
How Prevident is Revolutionizing Oral Care
5.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XV
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation